 |
|
Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study
Kwan Bok Lee, Kyung Min Koh, Young A Kwon, Sang Wroul Song, Byoung Yeop Kim, Jae Lim Chung
Korean J Ophthalmol. 2017;31(4):306-312. Published online 2017 Jul 13 DOI: https://doi.org/10.3341/kjo.2016.0056
|
|
Citations to this article as recorded by
 Update in Diagnostic Methods for Dry Eye Study
Manuel Alejandro Garza León, Ricardo Navarro-Saucedo, Francisco Beltrán Díaz de la Vega
Highlights of Ophthalmology.2023; 50(3E): 15. CrossRef Short Tear Breakup Time Could Exacerbate the Progression of Presbyopia in Women
Masahiko Ayaki, Kazuno Negishi, Pietro Emanuele Napoli
BioMed Research International.2022; 2022: 1. CrossRef Actualización en Métodos Diagnósticos para el Estudio del Ojo Seco
Dr. Ricardo Navarro-Saucedo, Dr. Manuel Alejandro Garza León, Dr. Francisco Beltrán Díaz de la Vega
Highlights of Ophthalmology.2022; 50(3S): 15. CrossRef Evaluation of effects of 3% diquafosol ophthalmic solution on preocular tear film stability after trabeculectomy
Qian Liu, Wenjun Cheng, Changgeng Liu, Xin Jin, Shuai Ming, Duo Zhao, Xiaomei Feng
International Ophthalmology.2022; 43(6): 1903. CrossRef Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study
Shima Fukuoka, Reiko Arita
Scientific Reports.2019;[Epub] CrossRef The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice
Keisuke Ikeda, Cem Simsek, Takashi Kojima, Kazunari Higa, Motoko Kawashima, Murat Dogru, Takahiko Shimizu, Kazuo Tsubota, Jun Shimazaki
Graefe's Archive for Clinical and Experimental Ophthalmology.2018; 256(4): 739. CrossRef
|